{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:57:09Z","timestamp":1783508229414,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.ijcard.2008.12.068","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T09:16:44Z","timestamp":1232615804000},"page":"126-132","source":"Crossref","is-referenced-by-count":42,"title":["Age-related differences in the pathogenesis of calcific aortic stenosis: The potential role of resistin"],"prefix":"10.1016","volume":"142","author":[{"given":"Dania","family":"Mohty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Pibarot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Despr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Cartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Arsenault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ijcard.2008.12.068_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/heart.89.7.801","article-title":"Calcific aortic stenosis: from bench to the bedside-emerging clinical and cellular concepts","volume":"89","author":"Rajamannan","year":"2003","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.ijcard.2008.12.068_bib2","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.ATV.19.5.1218","article-title":"Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves","volume":"19","author":"Olsson","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.ijcard.2008.12.068_bib3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.CIR.90.2.844","article-title":"Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies","volume":"90","author":"Otto","year":"1994","journal-title":"Circulation"},{"issue":"9 Suppl","key":"10.1016\/j.ijcard.2008.12.068_bib4","first-page":"I229","article-title":"Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway","volume":"112","author":"Rajamannan","year":"2005","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ijcard.2008.12.068_bib5","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jacc.2006.02.040","article-title":"Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation","volume":"47","author":"Caira","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ijcard.2008.12.068_bib6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/01.mol.0000137229.00020.fe","article-title":"Hyperlipidaemia and aortic valve disease","volume":"15","author":"Rossebo","year":"2004","journal-title":"Curr Opin Lipidol"},{"issue":"3","key":"10.1016\/j.ijcard.2008.12.068_bib7","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","article-title":"Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study","volume":"29","author":"Stewart","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ijcard.2008.12.068_bib8","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/0735-1097(93)90249-Z","article-title":"Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample","volume":"21","author":"Lindroos","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.ijcard.2008.12.068_bib9","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0002-9149(99)80760-7","article-title":"Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Quebec Cardiovascular Study)","volume":"75","author":"Lamarche","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2008.12.068_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.med.53.082901.104057","article-title":"Lipotoxic diseases","volume":"53","author":"Unger","year":"2002","journal-title":"Annu Rev Med"},{"issue":"4","key":"10.1016\/j.ijcard.2008.12.068_bib11","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2337\/diabetes.51.4.1016","article-title":"Leptin resistance during aging is independent of fat mass","volume":"51","author":"Gabriely","year":"2002","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.ijcard.2008.12.068_bib12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.arr.2006.03.004","article-title":"Lipotoxicity, overnutrition and energy metabolism in aging","volume":"5","author":"Slawik","year":"2006","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.ijcard.2008.12.068_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cardiores.2005.09.015","article-title":"Resistin is secreted from macrophages in atheromas and promotes atherosclerosis","volume":"69","author":"Jung","year":"2006","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.ijcard.2008.12.068_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2796.2004.01306.x","article-title":"The current biology of resistin","volume":"255","author":"Steppan","year":"2004","journal-title":"J Intern Med"},{"issue":"7","key":"10.1016\/j.ijcard.2008.12.068_bib15","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.CIR.0000155620.10387.43","article-title":"Resistin is an inflammatory marker of atherosclerosis in humans","volume":"111","author":"Reilly","year":"2005","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcard.2008.12.068_bib16","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1161\/01.ATV.20.3.807","article-title":"Segregation analysis of apolipoproteins A-1 and B-100 measured before and after an exercise training program: the HERITAGE Family Study","volume":"20","author":"An","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.ijcard.2008.12.068_bib17","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1161\/01.ATV.0000227513.13697.ac","article-title":"Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more)","volume":"26","author":"O'Brien","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.ijcard.2008.12.068_bib18","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1136\/hrt.2005.086595","article-title":"Distribution of SPARC during neovascularisation of degenerative aortic stenosis","volume":"92","author":"Charest","year":"2006","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ijcard.2008.12.068_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/ATVBAHA.107.154989","article-title":"Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis","volume":"28","author":"Mohty","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.ijcard.2008.12.068_bib20","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/S0022-2275(20)31529-7","article-title":"Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity","volume":"42","author":"Pascot","year":"2001","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.ijcard.2008.12.068_bib21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01643.x","article-title":"The apoB\/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy \u2013 a review of the evidence","volume":"259","author":"Walldius","year":"2006","journal-title":"J Intern Med"},{"issue":"15","key":"10.1016\/j.ijcard.2008.12.068_bib22","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1001\/jama.290.15.2030","article-title":"Unique lipoprotein phenotype and genotype associated with exceptional longevity","volume":"290","author":"Barzilai","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ijcard.2008.12.068_bib23","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.CIR.0000084503.91330.49","article-title":"Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction","volume":"108","author":"Verma","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcard.2008.12.068_bib24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/hc0502.102969","article-title":"Monocyte\/macrophage regulation of vascular calcification in vitro","volume":"105","author":"Tintut","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2008.12.068_bib25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.ATV.16.4.523","article-title":"Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis","volume":"16","author":"O'Brien","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.ijcard.2008.12.068_bib26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijcard.2004.08.079","article-title":"Age-related changes in aortic valve with emphasis on the relation between pressure loading and thickened leaflets of the aortic valves","volume":"103","author":"Lin","year":"2005","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ijcard.2008.12.068_bib27","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.ATV.20.4.1123","article-title":"Aging influences development and progression of early aortic atherosclerotic lesions in cholesterol-fed rabbits","volume":"20","author":"Orlandi","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"23","key":"10.1016\/j.ijcard.2008.12.068_bib28","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ijcard.2008.12.068_bib29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jacc.2006.07.072","article-title":"Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis","volume":"49","author":"Moura","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ijcard.2008.12.068_bib30","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0006-291X(02)02841-3","article-title":"Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators","volume":"300","author":"Patel","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"9493","key":"10.1016\/j.ijcard.2008.12.068_bib31","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2008.12.068_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijcard.2008.11.048","article-title":"Ethical authorship and publishing","volume":"131","author":"Coats","year":"2009","journal-title":"Int J Cardiol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527308014964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527308014964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T09:20:07Z","timestamp":1632993607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527308014964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0167527308014964"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2008.12.068","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}